FDA Qualification of MolecuLightDX Marks a New Era in Wound Care Innovation MolecuLight's innovative wound measurement device, MolecuLightDX®, receives FDA qualification, enabling enhanced evaluations in wound care, fostering clinical research.

FDA Qualification of MolecuLightDX Marks a New Era in Wound Care Innovation #USA #Pittsburgh #Wound_Care #MolecuLightDX #FDA_Qualification

Integral Molecular's Membrane Proteome Array Advances Toward FDA Qualification Integral Molecular is one step closer to obtaining FDA qualification for its Membrane Proteome Array, a vital tool in drug development to assess antibody specificity.

Integral Molecular's Membrane Proteome Array Advances Toward FDA Qualification #USA #Philadelphia #Integral_Molecular #Membrane_Proteome_Array #FDA_Qualification